Tag Archives: Price

NICE blames BioMarin for Brineura rejection after price talks break down

BioMarin and England’s cost-effectiveness gatekeeper have been negotiating for a year, but that hasn’t helped the rare-disease specialist secure reimbursement for its Batten disease drug Brineura. Friday, the National Institute for Health and Care Excellence (NICE) published draft guidance sticking with its earlier decision not to endorse Brineura in children with the disease, an inherited… Read More »

Campaigners urge the Government to end NHS price war over £105,000 cystic fibrosis 'wonder drug'

Campaigners urge the Government to end NHS price war over £105,000 cystic fibrosis ‘wonder drug’ which could extend thousands of children’s lives Orkambi could almost half the speed of lung damage in children with the illness It could extend the lives of patients who often die before reaching middle age Manufacturer Vertex turned down the… Read More »

Bristol-Myers yanked its Celgene bid days before deadline—and got a better price

On Dec. 10, Bristol-Myers Squibb made what it said was its final offer to acquire Celgene. But it turns out that wasn’t the case. It ended up scoring a better deal instead. Just days before a Jan. 2 deadline Bristol-Myers itself had set for wrapping up an agreement, the New Jersey drugmaker pulled that proposal—$ 57… Read More »